【発明の名称】12-および13-臭素-エルゴリン誘導体、その製法およびこれを含有する抑うつ性疾患症候群の精神障害の治療剤

Title:

【発明の名称】12-および13-臭素-エルゴリン誘導体、その製法およびこれを含有する抑うつ性疾患症候群の精神障害の治療剤

Document Type and Number:

Japanese Patent JPH0670050

Kind Code:

B2

Abstract:

Novel 12- and 13-bromoergoine derivatives are suitable as medicines for treating psychic disorders of the depressive array of symptoms and also as intermediates.

More Like This:

JP2004501956	Gel formed by the interaction of polyvinylpyrrolidone and chitosan derivatives
JP2004512305	Combination of transdermal therapeutic systems containing dopamine agonists with oral and / or parenteral formulations for the treatment of dopaminergic disease states
WO/1993/011743	MEDICAMENTS

Inventors:

Gerhard Sauer
Joseph Heintle
Gertrude Schuler
Helmut Wuerter

Application Number:

JP21989186A

Publication Date:

September 07, 1994

Filing Date:

September 19, 1986

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Schie-Ring Actien Gezershaft

International Classes:

A61K31/48; A61P9/12; A61P25/00; A61P25/02; A61P25/18; A61P25/24; A61P25/26; C07D457/12; (IPC1-7): C07D457/12; A61K31/48

Attorney, Agent or Firm:

Toshio Yano (1 outside)

Next Patent: １，２−置換されたエルゴリン誘導体、該製法及び該誘導体を含有する精�...